Natco Pharma

NATCOPHARM · NSE

— · —

₹889

Closing price — 19 Jun 2026

Market cap ₹15,959 Cr · EPS ₹34.87

Loading financial data for Natco Pharma…

Valuation

Blended fair value using DCF and peer comparison methods.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Branded generics & specialty pharma · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Natco Pharma NATCOPHARM · you	₹15,959 Cr	11.3×	1.7×	11.2×	15.4%	34.8%	14.6%
Sector median	—	36.1×	5.7×	24.6×	15.4%	13.7%	11.9%
Biocon BIOCON	₹67,470 Cr	145.1×	1.9×	25.6×	1.1%	2.3%	14.8%
Alkem Laboratories ALKEM	₹63,998 Cr	27.8×	4.6×	22.8×	16.7%	15.6%	8.2%
Abbott India ABBOTINDIA	₹55,558 Cr	35.7×	11.6×	29.4×	32.5%	22.4%	9.0%
Ipca Laboratories IPCALAB	₹41,806 Cr	36.3×	5.1×	22.4×	14.2%	11.8%	15.6%
Gland Pharma GLAND	₹37,695 Cr	36.8×	3.6×	23.5×	9.9%	16.0%	21.1%
Glaxosmithkline Pharmaceuticals GLAXO	₹37,177 Cr	35.9×	16.4×	28.3×	45.7%	27.1%	5.5%
Emcure Pharmaceuticals EMCURE	₹33,796 Cr	35.8×	6.7×	19.9×	18.7%	10.0%	15.4%
Wockhardt WOCKPHARMA	₹30,662 Cr	144.1×	6.2×	59.0×	4.3%	6.3%	8.4%

Peer comparison verdict

Natco trades at a discount to sector peers on P/E (11.3× vs median 36.1×). This may signal undervaluation — or reflect lower expected growth or higher perceived risk versus the peer group.

Business quality

Key profitability, efficiency, and solvency metrics.

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is loading…

Cash flow

Where cash comes from and where it goes.

Operating CFInvesting CFFinancing CFFree cash flow

Operating CF — Cash earned from running the business. The core engine of financial health.

Investing CF — Cash spent on assets and equipment. Negative is normal — it means the company is investing in growth.

Financing CF — Cash from borrowing or repaying loans and dividends. Negative means debt is being repaid.

Free cash flow — Operating CF minus capex. Cash left after keeping the business running. Positive and growing is ideal.

Operating CF

₹1,768.3 Cr

Investing CF

₹0 Cr

Financing CF

₹0 Cr

Free cash flow

₹1,377.2 Cr

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

How the company is funded — equity is owners' money, debt is long-term borrowing, current liabilities are short-term obligations.

Equity

Debt

Current liabilities

Total assets

—

Total debt

₹706 Cr

Equity

₹9,221 Cr

Debt / Equity

0.08×

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.